Event Brief
Apr 28, 2026 at 1:00 PM ET
Novartis, Amgen, Eli Lilly target bad cholesterol for heart drugs
By The BriefBrief
Novartis, Amgen, and Eli Lilly are betting that lowering a bad cholesterol type will drive next heart drug blockbusters.
WHO: Novartis, Amgen, Eli Lilly
WHAT: Pharma development strategy targeting a bad form of cholesterol for cardiology drugs
WHEN: Apr 27, 2026 at 3:28 PM ET
WHERE: Location not specified
WHY: They believe slashing levels of a particularly bad form of cholesterol could deliver next blockbusters.
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Amazon faces months of repairs after drone strikes
Amazon
May 1, 2026 at 3:23 PM ET
Minnesota bans fake AI nudes; app makers face $500K
Minnesota
May 1, 2026 at 3:23 PM ET
Page 21414 of 21414
Same format. Every time.
Continue reading — sign in or create a free account with
